Factors Associated With Major Bleeding Events: Insights From the ROCKET AF Trial (Rivaroxaban Once-daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)

OBJECTIVES: This study sought to report additional safety results from the ROCKET AF (Rivaroxaban Once-daily oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). BACKGROUND: The ROCKET AF trial demonstrated similar r...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Goodman, Shaun G., Wojdyla, Daniel M., Piccini, Jonathan P., White, Harvey D., Paolini, John F., Nessel, Christopher C., Berkowitz, Scott D., Mahaffey, Kenneth W., Patel, Manesh R., Sherwood, Matthew W., Becker, Richard C., Halperin, Jonathan L., Hacke, Werner, Singer, Daniel E., Hankey, Graeme J., Breithardt, Gunter, Fox, Keith A. A., Califf, Robert M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2013
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4206565/
https://ncbi.nlm.nih.gov/pubmed/24315894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2013.11.013
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items